480 related articles for article (PubMed ID: 29258183)
1. The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.
Fastrès A; Felice F; Roels E; Moermans C; Corhay JL; Bureau F; Louis R; Clercx C; Guiot J
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258183
[TBL] [Abstract][Full Text] [Related]
2. Microbiome in interstitial lung disease: from pathogenesis to treatment target.
Salisbury ML; Han MK; Dickson RP; Molyneaux PL
Curr Opin Pulm Med; 2017 Sep; 23(5):404-410. PubMed ID: 28650861
[TBL] [Abstract][Full Text] [Related]
3. Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.
Amati F; Stainer A; Mantero M; Gramegna A; Simonetta E; Suigo G; Voza A; Nambiar AM; Cariboni U; Oldham J; Molyneaux PL; Spagnolo P; Blasi F; Aliberti S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055163
[TBL] [Abstract][Full Text] [Related]
4. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
[No Abstract] [Full Text] [Related]
5. Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study.
Valenzi E; Yang H; Sembrat JC; Yang L; Winters S; Nettles R; Kass DJ; Qin S; Wang X; Myerburg MM; Methé B; Fitch A; Alder JK; Benos PV; McVerry BJ; Rojas M; Morris A; Kitsios GD
Thorax; 2021 Mar; 76(3):239-247. PubMed ID: 33268457
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.
Spagnolo P; Molyneaux PL; Bernardinello N; Cocconcelli E; Biondini D; Fracasso F; Tiné M; Saetta M; Maher TM; Balestro E
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717661
[TBL] [Abstract][Full Text] [Related]
7. Impaired diversity of the lung microbiome predicts progression of idiopathic pulmonary fibrosis.
Takahashi Y; Saito A; Chiba H; Kuronuma K; Ikeda K; Kobayashi T; Ariki S; Takahashi M; Sasaki Y; Takahashi H
Respir Res; 2018 Feb; 19(1):34. PubMed ID: 29486761
[TBL] [Abstract][Full Text] [Related]
8. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy.
Varone F; Gibiino G; Gasbarrini A; Richeldi L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6379-6386. PubMed ID: 31364146
[TBL] [Abstract][Full Text] [Related]
10. The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis.
Invernizzi R; Molyneaux PL
Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285290
[TBL] [Abstract][Full Text] [Related]
11. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of the lung microbiome in pulmonary fibrosis.
Lipinski JH; Moore BB; O'Dwyer DN
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L675-L682. PubMed ID: 32877221
[TBL] [Abstract][Full Text] [Related]
13. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.
Tong X; Su F; Xu X; Xu H; Yang T; Xu Q; Dai H; Huang K; Zou L; Zhang W; Pei S; Xiao F; Li Y; Wang C
Front Cell Infect Microbiol; 2019; 9():149. PubMed ID: 31165050
[TBL] [Abstract][Full Text] [Related]
14. Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis.
Molyneaux PL; Cox MJ; Wells AU; Kim HC; Ji W; Cookson WO; Moffatt MF; Kim DS; Maher TM
Respir Res; 2017 Feb; 18(1):29. PubMed ID: 28143484
[TBL] [Abstract][Full Text] [Related]
15. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Molyneaux PL; Cox MJ; Willis-Owen SA; Mallia P; Russell KE; Russell AM; Murphy E; Johnston SL; Schwartz DA; Wells AU; Cookson WO; Maher TM; Moffatt MF
Am J Respir Crit Care Med; 2014 Oct; 190(8):906-13. PubMed ID: 25184687
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Role of Bioactive Food Ingredients and the Microbiome in Idiopathic Pulmonary Fibrosis.
Mercader-Barceló J; Truyols-Vives J; Río C; López-Safont N; Sala-Llinàs E; Chaplin A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842664
[TBL] [Abstract][Full Text] [Related]
17. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
Huang Y; Ma SF; Espindola MS; Vij R; Oldham JM; Huffnagle GB; Erb-Downward JR; Flaherty KR; Moore BB; White ES; Zhou T; Li J; Lussier YA; Han MK; Kaminski N; Garcia JGN; Hogaboam CM; Martinez FJ; Noth I;
Am J Respir Crit Care Med; 2017 Jul; 196(2):208-219. PubMed ID: 28157391
[TBL] [Abstract][Full Text] [Related]
18. Respiratory microbiome in IPF: cause, effect, or biomarker?
Molyneaux PL; Maher TM
Lancet Respir Med; 2014 Jul; 2(7):511-3. PubMed ID: 24767768
[No Abstract] [Full Text] [Related]
19. Dysregulated Lung Commensal Bacteria Drive Interleukin-17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles.
Yang D; Chen X; Wang J; Lou Q; Lou Y; Li L; Wang H; Chen J; Wu M; Song X; Qian Y
Immunity; 2019 Mar; 50(3):692-706.e7. PubMed ID: 30824326
[TBL] [Abstract][Full Text] [Related]
20. The Bleomycin Model of Pulmonary Fibrosis.
Liu T; De Los Santos FG; Phan SH
Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
